Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-06

FDA Approved: TOLVAPTAN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a generic version of tolvaptan under an Original Application (ANDA) filed by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)